The elucidation of PHLPP1 involvement will pave the way for further analyses aimed at explaining its role in placental alterations in the context of metabolic disorders and its potential targetability for the treatment of negative consequences of diabetes. The gene discussed is PHLPP1; the disease is Other metabolic disease.